ArticleJournal of assisted reproduction and genetics2026
Novel heterozygous GMNN variants in human early embryonic arrest involving CHK1‑mediated cell cycle dysregulation.
Article in Journal of assisted reproduction and genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo investigate the genetic determinants underlying human early embryonic arrest (EA).
methodsWhole‑exome sequencing was performed to screen for candidate variants, followed by Sanger sequencing for family‑based validation. The effects of identified variants on Geminin subcellular localization were examined via immunofluorescence, while their impact on CHK1 pathway activation and DNA damage was assessed in HEK‑293 cells using western blot. Patient‑derived arrested embryos were also stained for γH2AX to evaluate DNA damage in situ. In addition, transcriptomic profiling was conducted to explore the broader biological consequences of GMNN variants during early human embryogenesis.
resultsWe identified two heterozygous GMNN variants-c.94 T > C (p.Ser32Pro) and c.601_606del (p.Ser201_Ser202del)-in two families presenting with female infertility due to EA. Functional studies revealed that these variants perturb cell cycle regulation, accompanied by CHK1 activation, elevated DNA damage levels, and altered nuclear distribution of Geminin. Transcriptomic analysis of patient embryos further confirmed substantial disruptions in cell cycle-related pathways and increased DNA damage, consistent with the cellular findings.
conclusionsOur findings expand the mutational and phenotypic spectrum of GMNN‑associated infertility and reinforce its critical role in cell cycle control during preimplantation development. The distinct transcriptomic signatures arising from different GMNN variants provide mechanistic insights into embryo arrest and offer potential molecular diagnostic markers as well as avenues for individualized therapeutic strategies.
Indexed as
Identifiers
42891780What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.